John David Finley, Chief Financial Officer at PALISADE BIO, INC. (PALI), bought 100,000 shares at $0.25 ($25K) on 2022-08-16, disclosed to the SEC on 2022-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| PALI | BUY | 2024-05-28 | $5K | — | Filing → |
| PALI | BUY | 2024-02-07 | $5K | — | Filing → |
| PALI | BUY | 2024-02-01 | $6K | — | Filing → |